Treatment Adherence and Compliance in Children and Adolescents on ADHD [attention-deficit hyperactivity disorder] Medication and Emotional Expression in Clinical Practice.

Trial Profile

Treatment Adherence and Compliance in Children and Adolescents on ADHD [attention-deficit hyperactivity disorder] Medication and Emotional Expression in Clinical Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2009

At a glance

  • Drugs Atomoxetine; Central nervous system stimulants
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Acronyms COMPLY
  • Sponsors Eli Lilly
  • Most Recent Events

    • 28 Aug 2009 Actual patient number (518) added as reported by ClinicalTrials.gov.
    • 28 Aug 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
    • 28 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top